The Clock Is Ticking On Karyopharm Therapeutics
Karyopharm Therapeutics Inc (KPTI) shares were down today as the company awaits the FDA’s decision on its Selinexor new drug application (“NDA”). The company’s stock dropped sharply on Friday, losing around 50% of its value due to FDA notes being leaked, in which the FDA voiced skepticism as to the benefit of approving the new […]
Read Article